Protein inhibitor of activated STAT-1 is downregulated in gastric cancer tissue and involved in cell metastasis

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2149-2155

  Chen, Ping ^a   Zhao, Deshou ^b   Sun, Yunwei ^a   Huang, Liya ^a   Zhang, Shuxian ^a   Yuan, Yaozong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Gastric cancer; MAPK signaling pathway; Migration; Protein inhibitor of activated STAT 1

Indexed keywords

ADENOVIRUS VECTOR; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHATE BUFFERED SALINE; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT 1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL LINE; CELL STRAIN SGC7901; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STOMACH CANCER; TISSUE MICROARRAY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN INHIBITORS OF ACTIVATED STAT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; STAT1 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84868112703     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2030     Document Type: Conference Paper

References (21)

1. Bornschein J, Rokkas T, Selgrad M, et al: Gastric cancer: clinical aspects, epidemiology and molecular background. Helicobacter, 16(Suppl 1):45-52, 2011.
2. Liu B, Yang R, Wong KA, et al: Negative regulation of N F-kappaB signaling by PIAS1. Mol Cell Biol 25:1113-1123, 2005. (Pubitemid 40165817)
3. Tahk S, Liu B, Chernishof V, et al: Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation. Proc Natl Acad Sci USA 104:11643-11648, 2007. (Pubitemid 47175066)
4. Coppola D, Parikh V, Boulware D, et al: Substantially reduced expression of PIAS1 is associated with colon cancer development. J Cancer Res Clin Oncol 135:1287-1291, 2009.
5. Seger R and Krebs EG: The MAPK signaling cascade. FASEB J 9:726-735, 1995.
6. Whitmarsh AJ and Davis RJ: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607, 1996. (Pubitemid 26343761)
7. Graziosi L, Mencarelli A, Santorelli C, et al: Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. Eur J Pharmacol 674:143-152, 2012.
8. Huang J, Yao WY, Zhu Q, et al: XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer. Cancer Sci 101:559-567, 2010.
9. Liu J and Chen L: Current status and progress in gastric cancer with liver metastasis. Chin Med J 124:445-456, 2011.
10. Tian MM, Sun Y, Li ZW, et al: Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J Gastroenterol 18:368-374, 2012.
11. Jang BG and Kim W H: Molecularp at hology of gastriccarcinoma. Pathobiology 78:302-310, 2011.
12. Tai DJ, Hsu WL, Liu YC, et al: Novel role and mechanism of protein inhibitor of activated STAT1 in spatial learning. EMBO J 30:205-220, 2011.
13. Liu LM, Yan MG, Yang DH, et al: The expression of protein inhibitor of activated signal transducers and activators of transcription 3 in the evolutionary process of gastric cancer. Eur J Intern Med 22:e31-35, 2011.
14. Dhillon AS, Hagan S, Rath O, et al: MAP kinase signalling pathways in cancer. Oncogene 26:3279-3290, 2007. (Pubitemid 46763021)
15. Yang JJ, Cho LY, Ma SH, et al: Oncogenic CagA promotes gastric cancer risk via activating ERK signaling pathways: a nested case-control study. PLoS One 6:e21155, 2011.
16. Wang H, Sun Y, Liu S, et al: Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1/2 signaling pathway: role in epithelial cell proliferation and migration. FEMS Immunol Med Microbiol 63:82-92, 2011.
17. Mitsuno Y, Yoshida H, Maeda S, et al: Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells. Gut 49:18-22, 2001. (Pubitemid 32601874)
18. Matsuoka T, Adair JE, Lih FB, et al: Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice. Br J Cancer 103:1182-1191, 2010.
19. Haier J, Nasralla M and Nicolson GL: Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 231:11-24, 2000. (Pubitemid 30043934)
20. Yashiro M, Sunami T and Hirakawa K: CD54 expression is predictive for lymphatic spread in human gastric carcinoma. Dig Dis Sci 50:2224-2230, 2005. (Pubitemid 43106372)
21. Hara I, Miyake H, Hara S, et al: Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. J Urol 165:1769-1772, 2001. (Pubitemid 32410306)